Foreign Animal Disease Research Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
 

Research Project: INTERVENTION STRATEGIES TO SUPPORT THE GLOBAL CONTROL AND ERADICATION OF FOOT-AND-MOUTH DISEASE VIRUS (FMDV)

Location: Foreign Animal Disease Research

Title: Novel antiviral therapeutics to control foot-and-mouth disease

Authors
item Dias, Camila -
item Moraes, Mauro -
item Weiss, Marcelo -
item Diaz San Segundo, Fayna
item Perez-Martin, Eva -
item Salazar, Andres -
item De Los Santos, Teresa
item Grubman, Marvin

Submitted to: Journal of Interferon and Cytokine Research
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: May 28, 2012
Publication Date: August 27, 2012
Repository URL: http://handle.nal.usda.gov/10113/56095
Citation: Dias, C.C., Moraes, M.P., Weiss, M., Diaz San Segundo, F.C., Perez-Martin, E., Salazar, A.M., De Los Santos, T.B., Grubman, M.J. 2012. Novel antiviral therapeutics to control foot-and-mouth disease. Journal of Interferon and Cytokine Research. 32(10):462-473.

Interpretive Summary: Foot-and-mouth disease virus (FMDV) is an antigenically variable virus consisting of 7 serotypes and multiple subtypes within each serotype, and it causes an economically devastating disease of cloven-hoofed animals. Vaccines produced by chemical inactivation of virus are available, but there are concerns about their safety and they do not induce protection prior to about 7 days post vaccination. In the event of an FMD outbreak in a disease-free country such as the U.S., it is necessary to induce immediate protection in order to limit or inhibit disease spread prior to induction of vaccine induced immunity. We have previously shown that in cell culture all 7 serotypes of FMDV are inhibited by type I interferon. Furthermore, we have constructed an adenovirus vector containing the gene for type I interferon (Ad5-pIFN alpha) and demonstrated that swine inoculated with this vector are protected from viral infection when challenged, by intradermal inoculation, 1 day later with FMDV serotypes A24, O1 Manisa, or Asia-1. We also demonstrated that Ad5-pIFN alpha protects against infection in swine that are challenged by direct contact to infected animals, which is a natural route of FMDV transmission. In this study we examined the potential of other inducers of the innate response to rapidly protect swine. We found that poly ICLC, a synthetic double-stranded RNA, given alone or in combination with Ad5-pIFN alpha can protect swine challenged one day after administration against infection with FMDV. Furthermore, the combination treatment induces a broader array of innate responses. These results suggest that a combination of poly ICLC and IFN plus FMD vaccine may represent a more economical approach to provide rapid and long-lasting protection to animals against FMD in an emergency outbreak situation.

Technical Abstract: Foot-and-mouth disease virus (FMDV) causes a highly contagious disease of cloven-hoofed animals. Vaccines require approximately 7 days to induce protection, thus prior to this time vaccinated animals are still susceptible to the disease. Our group has previously shown that swine inoculated with 1x10^11 focus forming units (FFU) of a replication-defective human adenovirus containing the gene for porcine interferon alpha (Adt-pIFN alpha) are sterilely protected from FMDV serotypes A24, O1 Manisa or Asia 1 when the animals are challenged 1 day post administration and protection can last for 3-5 days. Poly ICLC is a synthetic double stranded RNA that is a viral mimic and activates multiple innate immune pathways through interaction with TLR-3 and MDA-5. It is a potent inducer of IFNs. In this study, we initially examined the effect of poly IC and IFN-alpha on FMDV replication and gene induction in cell culture. Poly ICLC alone or combined with Adt-pIFN alpha was then evaluated for its therapeutic efficacy in swine against intradermal challenge with FMDV A24, 1 day post treatment. Groups of swine were subcutaneously inoculated with poly ICLC alone (4 or 8 mg) or in combination with different doses of Adt-pIFN alpha (2.5x10^9, 1x10^9 or 2.5x10^8 FFU). While different degrees of protection were achieved in all the treated animals, a dose of 8 mg of poly ICLC alone or combined with 1x10^9 FFU of Adt-pIFN alpha was sufficient to sterilely protect swine when challenged 24 h later with FMDV A24. IFN stimulated gene (ISG) expression in peripheral blood mononuclear cells at 1 day post treatment was broader and higher in protected animals than in non-protected animals. These data indicate that poly ICLC is a potent stimulator of IFN and ISGs in swine and at an adequate dose is sufficient to induce complete protection against FMD.

   

 
Project Team
Grubman, Marvin
Rieder, Aida - Elizabeth
Golde, William - Bill
Rodriguez, Luis
Borca, Manuel
De Los Santos, Teresa
Arzt, Jonathan
Zhu, James
 
Publications
   Publications
 
Related National Programs
  Animal Health (103)
 
Related Projects
   ANALYSIS OF T CELL RESPONSE TO FOOT-AND-MOUTH DISEASE VIRUS INFECTION
   FOREIGN ANIMAL DISEASE (FAD) COUNTERMEASURE DEVELOPMENT
   TESTING FOOT-AND-MOUTH DISEASE VIRUS (FMDV) VACCINE POTENCY IN GENETICALLY DEFINED CATTLE
   APPLYING EPIDEMIOLOGICAL MODELS TO UNDERSTANDING THE EMERGENCE OF NEW FMD VIRUS ANTIGENIC AND GENETIC VARIANTS
   ANTIGENIC AND GENETIC CHARACTERIZATION OF FOOT-AND-MOUTH DISEASE VIRUSES IN INDIA: APPLICATION TO EFFECTIVE MOLECULAR VACCINES
   ANTIGENIC STRUCTURE OF FMDV CAPSID PROTEINS AND THE SELECTION OF APPROPRIATE CANDIDATE VACCINE STRAINS IN EMERGING FMD OUTBREAKS
   UNDERSTANDING NATURAL KILLER (NK) CELLS AND GAMMA-DELTA T CELLS IN VIRUS INFECTIONS OF CATTLE
   TRANSMISSION AND EVOLUTION STUDIES OF FMDV IN LIVESTOCK IN THE LAKE CHAD BASIN
   MOLECULAR EPIDEMIOLOGY, SURVEILLANCE, AND PREDICTIVE TOOLS FOR FOOT-AND-MOUTH DISEASE CONTROL IN VIETNAM
   VIRAL DETERMINANT OF PATHOGENESIS AND VIRULENCE: A STUDY MODEL BASED ON THE FMDV OUTBREAK STRAIN A ARGENTINA 2001
   A MODERN APPROACH FOR THE DEVELOPMENT OF CATTLE VACCINES FOR CRITICAL BOVINE DISEASES IMPACTING SMALLHOLDER FARMS IN SUB-SAHARAN AFRICA
   STUDY OF INTERACTION BETWEEN FOOT-AND-MOUTH DISEASE VIRUS AND HOST PROTEINS DURING INFECTION
   FOOT-AND-MOUTH DISEASE MONOCLONAL ANTIBODIES PRODUCTION IN CAMELS
   ANTIGENIC PROFILING AND GENETIC ANALYSIS OF FOOT-AND-MOUTH DISEASE VIRUS IN UGANDA
   COUNTERMEASURES FOR FOOT-AND-MOUTH DISEASE UTILIZING DIAGNOSTICS, BIOTHERAPEUTICS, A NOVEL VACCINE PLATFORM AND IMPROVED CHALLENGE SYSTEMS
   EVALUATION OF INFRARED THERMOGRAPHY AS A SCREENING METHOD FOR EARLY DETECTION OF FOOT-AND-MOUTH DISEASE INFECTED CATTLE
   INVESTIGATING POTENTIAL EXISTENCE OF CHRONIC, PERSISTENT FOOT-AND-MOUTH DISEASE VIRUS INFECTION IN DOMESTIC PIGS; IMPLICATIONS .. STRATEGIES
   MOLECULAR EPIDEMIOLOGY AND PATHOGENESIS STUDIES OF EMERGING FOOT-AND-MOUTH DISEASE STRAINS IN VIETNAM
   EPIDEMIOLOGY, VACCINES AND CONTROL OF FOOT-AND-MOUTH DISEASE IN PAKISTAN
   MOLECULAR EPIDEMIOLOGY AND BIOSURVEILLANCE OF FOOT-AND-MOUTH DISEASE IN ENDEMIC REGIONS OF CENTRAL ASISA, SOUTHEAST ASISA AND AFRICA
   IN VITRO EVALUATION OF THE CAPACITY OF FOOT-AND-MOUTH DISEASE VIRUS TO INITIATE T-INDEPENDENT HUMORAL RESPONSES IN A BOVINE MODEL
   UNDERSTANDING THE ECOLOGY OF FOOT-AND-MOUTH DISEASE VIRUSES CIRCULATING IN CAMEROON
   DEVELOPMENT OF IMPROVED MUCOSAL FOOT-AND-MOUTH DISEASE VIRUS VACCINES
   PREDICTING T CELL SPECIFITIES IN SWINE FOR VACCINE DEVELOPMENT
   DISINFECTION OF FOREIGN ANIMAL DISEASE VIRUSES ON SURFACES RELEVANT TO THE PORK PACKING INDUSTRY
   Evaluation of Recombinant Replication-Defective Adenoviruses Which Induce Anti-Viral Activity in Cattle
   Development of Novel Foot-and-Mouth Disease Virus with Multiple Mutations for Evaluation as Live Attenuated Diva Vaccine Candidate
   Determination of the Efficacy for Foot-and-Mouth Disease Vaccines in Merino Sheep
 
 
Last Modified: 05/19/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House